Trial Profile
Study of NAL 3221 for the treatment of herpes zoster virus infections (shingles)
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs NAL 3221 (Primary)
- Indications Herpes zoster
- Focus Adverse reactions
- 24 Aug 2016 New trial record